Agilent Technologies (NYSE:A) updated its FY18 earnings guidance on Wednesday. The company provided earnings per share guidance of $2.62-2.68 for the period, compared to the Thomson Reuters consensus earnings per share estimate of $2.59. The company issued revenue guidance of $4.885-4.905 billion, compared to the consensus revenue estimate of $4.75 billion.Agilent Technologies also updated its Q2 guidance to $0.61-0.63 EPS.

Several analysts recently issued reports on the company. Morgan Stanley reiterated an overweight rating on shares of Agilent Technologies in a report on Tuesday, November 14th. Zacks Investment Research lowered Agilent Technologies from a buy rating to a hold rating in a report on Thursday, November 16th. ValuEngine lowered Agilent Technologies from a buy rating to a hold rating in a report on Friday, December 1st. Robert W. Baird reiterated a buy rating and set a $72.00 target price on shares of Agilent Technologies in a report on Friday, November 24th. Finally, Barclays upped their target price on Agilent Technologies from $67.00 to $71.00 and gave the stock an overweight rating in a report on Tuesday, November 21st. Six analysts have rated the stock with a hold rating and eleven have assigned a buy rating to the company. Agilent Technologies presently has an average rating of Buy and a consensus target price of $69.25.

Agilent Technologies (NYSE A) traded up $1.36 during trading hours on Wednesday, reaching $69.70. The company’s stock had a trading volume of 3,632,650 shares, compared to its average volume of 2,254,274. The company has a quick ratio of 2.85, a current ratio of 3.30 and a debt-to-equity ratio of 0.37. The company has a market capitalization of $22,410.00, a price-to-earnings ratio of 33.19, a price-to-earnings-growth ratio of 2.07 and a beta of 1.28. Agilent Technologies has a 12-month low of $50.56 and a 12-month high of $75.00.

Agilent Technologies (NYSE:A) last released its quarterly earnings data on Monday, November 20th. The medical research company reported $0.67 earnings per share (EPS) for the quarter, beating the consensus estimate of $0.62 by $0.05. The firm had revenue of $1.19 billion for the quarter, compared to analyst estimates of $1.17 billion. Agilent Technologies had a return on equity of 16.95% and a net margin of 15.30%. The business’s revenue for the quarter was up 7.0% compared to the same quarter last year. During the same quarter in the prior year, the company earned $0.59 earnings per share. equities research analysts forecast that Agilent Technologies will post 2.58 earnings per share for the current fiscal year.

In other news, CEO Michael R. Mcmullen sold 22,481 shares of the stock in a transaction that occurred on Friday, November 17th. The stock was sold at an average price of $68.77, for a total transaction of $1,546,018.37. Following the transaction, the chief executive officer now owns 336,637 shares in the company, valued at $23,150,526.49. The sale was disclosed in a filing with the SEC, which is available through the SEC website. Also, CEO Michael R. Mcmullen sold 43,703 shares of the stock in a transaction that occurred on Friday, January 5th. The stock was sold at an average price of $70.00, for a total value of $3,059,210.00. Following the transaction, the chief executive officer now owns 302,837 shares in the company, valued at approximately $21,198,590. The disclosure for this sale can be found here. Insiders sold 219,991 shares of company stock worth $15,468,795 in the last 90 days.

COPYRIGHT VIOLATION NOTICE: This piece of content was originally posted by TheOlympiaReport and is the sole property of of TheOlympiaReport. If you are reading this piece of content on another website, it was copied illegally and reposted in violation of US and international trademark and copyright legislation. The original version of this piece of content can be read at https://theolympiareport.com/2018/02/14/agilent-technologies-a-updates-fy18-earnings-guidance.html.

Agilent Technologies Company Profile

Agilent Technologies, Inc provides application focused solutions that include instruments, software, services and consumables for the entire laboratory workflow. The Company serves the life sciences, diagnostics and applied chemical markets. It has three business segments: life sciences and applied markets business, diagnostics and genomics business, and Agilent CrossLab business.

Earnings History and Estimates for Agilent Technologies (NYSE:A)

Receive News & Ratings for Agilent Technologies Daily - Enter your email address below to receive a concise daily summary of the latest news and analysts' ratings for Agilent Technologies and related companies with MarketBeat.com's FREE daily email newsletter.